CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease
暂无分享,去创建一个
M. Fumagalli | F. Mannelli | A. Bosi | A. Cortelezzi | F. Ciceri | E. Angelucci | A. Rambaldi | R. Bassan | O. Spinelli | T. Intermesoli | E. Pogliani | C. Corti | S. Cortelazzo | G. Gianfaldoni | C. Romani | A. Scattolin | C. Cattaneo | E. Oldani | E. Borlenghi | D. Mattei | I. Cavattoni | E. Audisio
[1] Hermann Einsele,et al. Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] D. Weisdorf,et al. Allogeneic hematopoietic stem cell transplantation overcomes the adverse prognostic impact of CD20 expression in acute lymphoblastic leukemia. , 2011, Blood.
[3] M. Tallman,et al. Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia (B-ALL) Patients (pts) From the International UKALLXII/E2993 Trial: No Difference In Results Between B Cell Immunophenotypic Subgroups , 2010 .
[4] M. Andreeff,et al. Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] A. Levis,et al. Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Hong Chang,et al. Prognostic relevance of CD20 in adult B-cell precursor acute lymphoblastic leukemia , 2010, Haematologica.
[7] H. Dombret,et al. Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia , 2010, Haematologica.
[8] H. Kantarjian,et al. Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia. , 2009, Blood.
[9] T. Barbui,et al. Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL). , 2009, Blood.
[10] F. Behm,et al. Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemia. , 2006, Blood.
[11] F Lacombe,et al. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia , 1997, Leukemia.
[12] A. Look,et al. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study. , 1997, Blood.
[13] E. Paietta. Proposals for the immunological classification of acute leukemias. , 1995, Leukemia.
[14] A Orfao,et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). , 1995, Leukemia.